Cannabinoids and OCD: Promising Biology
Could the endocannabinoid system unlock OCD treatments? A look at current evidence on cannabinoids risks and why research hasn't yet made them standard care.
Articles
How to Join Minnesota’s Medical Cannabis Program
Discover how to join Minnesota's medical cannabis program: eligibility, registration steps, caregiver options, and what to expect at the registry and retailers.
Cannabis and Health: Where the Evidence Supports Benefits, and Where It Does Not
Explore what current evidence says about cannabis and health: where cannabinoids show promise and where popular claims are unsupported.
Medical Cannabis Use More Than Doubled in the U.S. Between 2013 and 2020
A nationwide study finds medical cannabis use more than doubles from 2013–2020, linked to legalization but not proof of effectiveness—what this means.
Cannabis Use Can Affect Anesthesia: Why Patients Should Tell Their Care Team
Learn how cannabis use can affect anesthesia and why you must disclose it to your surgical team for safer, tailored perioperative care.
Terpene Science Could Help Cannabis Brands Build More Consistent Products
Terpene science helps cannabis brands build consistent products—data-driven profiles, transparent labeling, and smarter formulations beyond strain names.
How Long Cannabis Can Be Detected, and Why That Does Not Equal Impairment
Discover how long cannabis stays detectable, why that differs from impairment, and the factors that affect test results - essential for safety and policy.
Medical Cannabis Has No Established Role in Treating Vibriosis Symptoms
Medical cannabis has no proven role in treating vibriosis; learn the evidence, what truly helps (hydration, antibiotics for severe cases), and prevention tips.
Cannabinoids Show Early Bone-Building Potential
Discover how cannabinoids may affect bone health, with preclinical hints on remodeling and CBD fracture healing, yet no proven osteoporosis benefit in humans.
Medicare Does Not Cover Medical Marijuana, But Some FDA-Approved Cannabinoid Drugs May Qualify
Medicare won't cover medical marijuana, but some FDA-approved cannabinoid medications may qualify under Part D; learn how your plan handles coverage.